A recently published study from Fred Hutch Cancer Center dramatically expands the number of FDA-approved cancer drugs ...
Immunotherapy trailblazer Dr. Stanley Riddell reflects on the science, setbacks and breakthroughs that helped transform T ...
Dr. Lisa Ni explains how proton therapy offers more precision when treating brain and central nervous system tumors in ...
Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...
Why should the immune system not be “boosted,” but instead supported through consistent, healthy habits? Learn how the immune ...
Cancer Center’s Community Grants Program has recently awarded 10 cancer prevention projects across Washington state up to $15 ...
A graduate student at Fred Hutch Cancer Center has produced a near real-time picture of how well the human immune system is ...
Tuberculosis and us — we go way back. Way, way back: Biomolecular evidence suggests that the bacterium responsible, Mycobacterium tuberculosis or an ancestor, might have hitched its wagon to ...
SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...
Fred Hutch Cancer Center psychologist and public health researcher Jonathan Bricker, PhD, talks about why people readily embrace dietary supplements ― which are unregulated by the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results